aOvaTechnologies

aOva Technologies is a biotechnology company specializing in the development of oral bioactive proteins to improve animal health and productivity. The company's core technology involves the use of specialized antibodies, such as IgY, delivered through animal feed to modulate biological pathways in the gut. By targeting specific hormones like cholecystokinin (CCK) and inflammatory cytokines, aOva's products enhance growth rates and feed efficiency in poultry and livestock without the use of traditional antibiotics. Founded as a spin-off from the University of Wisconsin-Madison, the company focuses on sustainable and antibiotic-free solutions for the global food animal industry. Their lead product targets CCK to naturally stimulate appetite and digestion, providing a non-drug alternative to growth-promoting antibiotics.